K-1592

N/A

Report date: 2022/11/23 09:04:16
NME

Base Information

Drug NameK-1592
Drug Alias NameK-1592
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsGlutamate [NMDA] receptor antagonistsNeuroprotectants
TargetsAcetylcholinesteraseGlutamate [NMDA] receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Hradec KraloveNational Institute Of Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Mental HealthUniversity Hospital Hradec Kralove
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A